Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F95T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,216
Award facts
- Contract value 100% obligated
- $32,216.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,216.18 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where it maintains operations as a major healthcare solutions provider and pharmaceutical distributor serving federal medical procurement needs.
This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Dupixent is a specialty biologic medication used in the treatment of eczema, asthma, and other conditions, reflecting the contractor's role in providing specialized pharmaceutical commodities across multiple therapeutic domains to the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26F95T3?
SPE2DR26F95T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F95T3 worth?
The government has obligated $32,216 on SPE2DR26F95T3.
Is contract SPE2DR26F95T3 an order under another contract?
Yes. SPE2DR26F95T3 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F95T3 competed?
The extent of competition for SPE2DR26F95T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award